FDA Issues 5-Point Action Plan For Artificial Intelligence/Machine Learning-Based SaMD
Executive Summary
A new guidance document and a promise to hold a public workshop are just two commitments made by the US agency in a 12 January action plan aimed at AI/ML-based software as a medical device.
You may also be interested in...
Analyst Insight: Top 2021 Health Care Trends On Display At RSNA
A confluence of factors promoting the rapid adoption of health care AI is expected to make 2021 a pivotal year for the technology, as demonstrated by product launches at RSNA 2020.
GOP Senator Wants Time Frame And Other Details On FDA’s AI/ML Action Plan
US Sen. Bill Cassidy says he wants more details about the FDA’s plans to regulate AI/ML medical software, including a time frame for publishing guidance documents.
Head Of New Digital Health Center Looking For A Few Good FDA Staff
Bakul Patel, director of the US agency’s new Digital Health Center of Excellence, tells Medtech Insight he’s looking to hire staff that want to shape the digital health regulatory landscape.